ArticleCurrent microbiology2013
Use of an algD promoter-driven expression system for the degradation of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) by Pseudomonas sp. HK-6.
Article in Current microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas sp. HK-6 is able to utilize hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) as a sole nitrogen source. The HK-6 strain was stimulated to produce an exopolymer, mainly alginate, as a stress response when grown in LB broth containing RDX, synthesizing ~230 μg/mL after 48 h. The algA mRNA levels in HK-6 increased by 7-8-fold after 2-6 h of exposure to 0.1 mM RDX, as measured by RT-qPCR. HK-6 was able to degrade ~25 % of 0.1 mM RDX after 20 days and 60 % after 50 days, whereas the pnrB null mutant only degraded less than 1 % after 50 days. The introduction of an algD promoter-pnrB gene fusion into the pnrB mutant fully restored RDX-degradation capability. To facilitate a study of PnrB action on RDX, a His6-PnrB fusion protein was heterologously expressed in E. coli BL21 cells, and the enzymatic activity on RDX was assayed by measuring the decrease in absorbance at 340 nm due to NADH oxidation. At the fixed condition of 0.1 mM RDX, 0.2 mM NADH, and 1 μg His6-PnrB, the absorbance at 340 nM gradually decreased and reached to its minimum value after 30 min. However, calculating the V max and K m values of PnrB for RDX was challenging due to extremely low solubility of RDX in water. The results clearly indicate the potential use of the algD promoter in studies of some genes in Pseudomonas species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.